Phase 3CompletedAge-related condition

Efficacy and Safety of Desmopressin Melt for the Treatment of Nocturia

A Randomized, Double Blind, Placebo Controlled, Parallel Group, Multi-Center Study With a Double Blind Extension Investigating the Efficacy and Safety of a Fast- Dissolving ("Melt") Formulation of Desmopressin for the Treatment of Nocturia in Adults

Sponsor
Ferring Pharmaceuticals (Industry)
Enrollment
799 enrolled
Conditions
Nocturia
Interventions
desmopressin acetate; Placebo
Ages
adults, older adults
Registry
NCT00477490

Full record on ClinicalTrials.gov

From the registry

The purpose of this study is to investigate the efficacy and safety of several doses of the melt formulation of desmopressin in a broad population of adult patients with nocturia.

Primary outcomes

  • Part I: Change From Baseline in Mean Number of Nocturnal Voids at Week 4
  • Part I: Percentage of Participants With Greater Than 33 Percent Reduction From Baseline in Mean Number of Nocturnal Voids at Week 4

History

  1. Results first posted

  2. Last registry update

  3. Primary completion

  4. Registered

  5. Started